Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ujwal Shinde

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nucleic Acids Research|March 13, 2023
The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processingYingxiao Chen, Yanping Li, Roselyn S Dai, et al.
Communications Biology|December 17, 2020
NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitorsRomel Somwar, Nicolle E Hofmann, Bryan Smith, et al.
Leukemia|May 11, 2018
Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypesMona M Hosseini, Stephen E Kurtz, Sherif Abdelhamed, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6 specific nanobody restricts M. tuberculosis growth in macrophagesTimothy A Bates, Mila Trank-Greene, Xammy Nguyenla, et al.
Elife|May 28, 2024
ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts <i>M. tuberculosis</i> growth in macrophagesTimothy A Bates, Mila Trank-Greene, Xammy Nguyenla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
Haematologica|February 13, 2025
Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemiaSunil K Joshi, Ariane Huang, Janét Pittsenbarger, et al.
Blood|September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AMLFei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nucleic Acids Research|March 13, 2023
The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processingYingxiao Chen, Yanping Li, Roselyn S Dai, et al.
Communications Biology|December 17, 2020
NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitorsRomel Somwar, Nicolle E Hofmann, Bryan Smith, et al.
Leukemia|May 11, 2018
Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypesMona M Hosseini, Stephen E Kurtz, Sherif Abdelhamed, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6 specific nanobody restricts M. tuberculosis growth in macrophagesTimothy A Bates, Mila Trank-Greene, Xammy Nguyenla, et al.
Elife|May 28, 2024
ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts <i>M. tuberculosis</i> growth in macrophagesTimothy A Bates, Mila Trank-Greene, Xammy Nguyenla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
Haematologica|February 13, 2025
Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemiaSunil K Joshi, Ariane Huang, Janét Pittsenbarger, et al.
Blood|September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AMLFei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Pageof 6